Christopher J. Dinsmore

3.4k total citations
47 papers, 1.8k citations indexed

About

Christopher J. Dinsmore is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Christopher J. Dinsmore has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 28 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Christopher J. Dinsmore's work include Chemical Synthesis and Analysis (13 papers), Microbial Natural Products and Biosynthesis (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Christopher J. Dinsmore is often cited by papers focused on Chemical Synthesis and Analysis (13 papers), Microbial Natural Products and Biosynthesis (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Christopher J. Dinsmore collaborates with scholars based in United States and Switzerland. Christopher J. Dinsmore's co-authors include Douglas C. Beshore, David A. Evans, Thomas R. Hoye, Deborah A. Evrard, Swati P. Mercer, Jeffrey L. Katz, B. Wesley Trotter, Paul S. Watson, Keith M. DeVries and James C. Barrow and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Christopher J. Dinsmore

47 papers receiving 1.7k citations

Peers

Christopher J. Dinsmore
Xun Sun China
Yoshiyasu Ichikawa Japan
Prabhat Arya Canada
Jeremy P. Scott United Kingdom
Frank E. McDonald United States
Zhiguo J. Song United States
Bing Zhou China
Zhijian Liu United States
Pierre van de Weghe France
Yaxi Yang China
Xun Sun China
Christopher J. Dinsmore
Citations per year, relative to Christopher J. Dinsmore Christopher J. Dinsmore (= 1×) peers Xun Sun

Countries citing papers authored by Christopher J. Dinsmore

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Dinsmore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Dinsmore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Dinsmore more than expected).

Fields of papers citing papers by Christopher J. Dinsmore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Dinsmore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Dinsmore. The network helps show where Christopher J. Dinsmore may publish in the future.

Co-authorship network of co-authors of Christopher J. Dinsmore

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Dinsmore. A scholar is included among the top collaborators of Christopher J. Dinsmore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Dinsmore. Christopher J. Dinsmore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ericsson, Anna, David J. Richard, Erik Wilker, et al.. (2024). FT-4202, a selective pyruvate kinase R activator for sickle cell disease. Experimental Hematology. 141. 104673–104673. 1 indexed citations
2.
Caravella, Justin A., R. Bruce Diebold, Anna Ericsson, et al.. (2020). Structure-Based Design and Identification of FT-2102 (Olutasidenib), a Potent Mutant-Selective IDH1 Inhibitor. Journal of Medicinal Chemistry. 63(4). 1612–1623. 111 indexed citations
3.
Deshmukh, Sujal V., Christopher J. Dinsmore, Fiona Elwood, et al.. (2016). Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(7). 1803–1808. 18 indexed citations
4.
Siu, Tony, Michael D. Altman, Matthew H. Katcher, et al.. (2014). The discovery of reverse tricyclic pyridone JAK2 inhibitors. Part 2: Lead optimization. Bioorganic & Medicinal Chemistry Letters. 24(6). 1466–1471. 6 indexed citations
5.
Beshore, Douglas C., Nigel J. Liverton, Charles McIntyre, et al.. (2010). Discovery of triarylethanolamine inhibitors of the Kv1.5 potassium channel. Bioorganic & Medicinal Chemistry Letters. 20(8). 2493–2496. 12 indexed citations
6.
Siu, Tony, Joon Jung, Craig Rosenstein, et al.. (2010). The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: Hit to lead. Bioorganic & Medicinal Chemistry Letters. 20(24). 7421–7425. 22 indexed citations
7.
Dinsmore, Christopher J., et al.. (2010). Parallel Synthesis of Ureas and Carbamates from Amines and CO2 under Mild Conditions. Organic Letters. 12(6). 1340–1343. 142 indexed citations
8.
Nanda, Kausik K., Matthew J. Cato, Stefanie A. Kane, et al.. (2006). Potent antagonists of the Kv1.5 potassium channel: Synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamides. Bioorganic & Medicinal Chemistry Letters. 16(22). 5897–5901. 11 indexed citations
9.
Dinsmore, Christopher J., C. Blair Zartman, Jeffrey M. Bergman, et al.. (2004). Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 14(3). 639–643. 8 indexed citations
10.
Dinsmore, Christopher J. & Ian M. Bell. (2003). Inhibitors of Farnesyltransferase and Geranylgeranyltransferase-I for Antitumor Therapy: Substrate-Based Design, Conformational Constraint and Biological Activity. Current Topics in Medicinal Chemistry. 3(10). 1075–1093. 26 indexed citations
11.
Beshore, Douglas C. & Christopher J. Dinsmore. (2003). Preparation of Ethyl 5-Iodo-1H-indole- 2-carboxylate. Synthetic Communications. 33(14). 2423–2427. 7 indexed citations
12.
Huber, Hans E., R. Robinson, Deborah D. Nahas, et al.. (2001). Anions Modulate the Potency of Geranylgeranyl-Protein Transferase I Inhibitors. Journal of Biological Chemistry. 276(27). 24457–24465. 16 indexed citations
13.
Bergman, Jeffrey M., Marc Abrams, Joseph P. Davide, et al.. (2001). Aryloxy substituted N-arylpiperazinones as dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I. Bioorganic & Medicinal Chemistry Letters. 11(11). 1411–1415. 25 indexed citations
14.
Buser, Carolyn A., Christopher J. Dinsmore, Christine Fernandes, et al.. (2001). High-Performance Liquid Chromatography/Mass Spectrometry Characterization of Ki4B-Ras in PSN-1 Cells Treated with the Prenyltransferase Inhibitor L-778,123. Analytical Biochemistry. 290(1). 126–137. 24 indexed citations
15.
Dinsmore, Christopher J., Jeffrey M. Bergman, Michael J. Bogusky, et al.. (2001). 3,8-Diazabicyclo[3.2.1]octan-2-one Peptide Mimetics:  Synthesis of a Conformationally Restricted Inhibitor of Farnesyltransferase. Organic Letters. 3(6). 865–868. 25 indexed citations
16.
MacTough, Suzanne C., Theresa M. Williams, Christopher J. Dinsmore, et al.. (1999). Non-thiol 3-aminomethylbenzamide inhibitors of farnesyl-protein transferase. Bioorganic & Medicinal Chemistry Letters. 9(14). 1991–1996. 28 indexed citations
17.
Dinsmore, Christopher J. & C. Blair Zartman. (1999). Arylmethanesulfonates are convenient latent phenols in the nucleophilic aromatic substitution reaction. Tetrahedron Letters. 40(21). 3989–3990. 11 indexed citations
18.
Evans, David A., Christopher J. Dinsmore, Paul S. Watson, et al.. (1998). Nonconventional Stereochemical Issues in the Design of the Synthesis of the Vancomycin Antibiotics: Challenges Imposed by Axial and Nonplanar Chiral Elements in the Heptapeptide Aglycons. Angewandte Chemie International Edition. 37(19). 2704–2708. 139 indexed citations
19.
Evans, David A., Percy H. Carter, Christopher J. Dinsmore, et al.. (1997). Mild nitrosation and hydrolysis of polyfunctional amides. Tetrahedron Letters. 38(26). 4535–4538. 52 indexed citations
20.
Dinsmore, Christopher J., Theresa M. Williams, Kelly Hamilton, et al.. (1997). DIARYLETHER INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE. Bioorganic & Medicinal Chemistry Letters. 7(10). 1345–1348. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xun Sun Breakdown of academic impact, for papers by Yoshiyasu Ichikawa Breakdown of academic impact, for papers by Prabhat Arya Breakdown of academic impact, for papers by Jeremy P. Scott Breakdown of academic impact, for papers by Frank E. McDonald Breakdown of academic impact, for papers by Zhiguo J. Song Breakdown of academic impact, for papers by Bing Zhou Breakdown of academic impact, for papers by Zhijian Liu Breakdown of academic impact, for papers by Pierre van de Weghe Breakdown of academic impact, for papers by Yaxi Yang
Rankless by CCL
2026